Figure 3.
Kaplan–Meier analysis of progression-free survival according to FoxP3 and CD68 co-expression in (A) malignant melanoma, median PFS 17.0 vs. 3.9 months, p = 0.008; and (B) NSCLC, median PFS 19.0 vs. 2.3 months, p < 0.001.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.